What is Zacks Research’s Forecast for Novavax Q1 Earnings?
Novavax, Inc. (NASDAQ:NVAX – Free Report) – Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Novavax in a research note issued to investors on Wednesday, February 26th. Zacks Research analyst S. Ganoria now expects that the biopharmaceutical company will earn ($0.65) per share for the quarter, down from their prior estimate […]
Novavax, Inc. (NASDAQ:NVAX – Free Report) – Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Novavax in a research note issued to investors on Wednesday, February 26th. Zacks Research analyst S. Ganoria now expects that the biopharmaceutical company will earn ($0.65) per share for the quarter, down from their prior estimate […]
